Bulletin
Investor Alert

Axsome Therapeutics Inc.

NAS: AXSM

GO
/marketstate/country/us

After Hours

/zigman2/quotes/200978956/composite

$

83.33

Change

+1.68 +2.06%

Volume

Volume 25,758

Sep 18, 2020, 7:26 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/200978956/composite

Previous close

$ 79.08

$ 81.65

Change

+2.57 +3.25%

Day low

Day high

$79.07

$83.60

Open
Open: 81.34

52 week low

52 week high

$13.64

$109.94

Open

Market cap

$3.04B

Average volume

405,982

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-2.64

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/axsm

MarketWatch News on AXSM

  1. Axsome Therapeutics stock price target raised to $140 from $100 at SunTrust RH

    9:00 a.m. Dec. 31, 2019

    - Tomi Kilgore

  2. Here are the best-performing Nasdaq stocks of 2019

    10:06 a.m. Dec. 28, 2019

    - Philip van Doorn

  3. Bed Bath & Beyond and 3 more stocks showing momentum

    1:50 p.m. Dec. 19, 2019

    - Harry Boxer

  4. Axsome Therapeutics stock price target raised to $60 from $50 at SunTrust RH

    8:53 a.m. Dec. 4, 2019

    - Tomi Kilgore

  5. Harder Times Can Be Good Times for Small-Cap Momentum Investing

    7:00 a.m. July 18, 2019

    - Barron's Online

  6. Axsome Therapeutics initiated at buy with $50 price target at SunTrust Robinson Humphrey

    7:58 a.m. May 28, 2019

    - Tonya Garcia

  7. Axsome Therapeutics started at outperform with $25 stock price target at SVB Leerink

    7:59 a.m. April 8, 2019

    - Tomi Kilgore

  8. Axsome Therapeutics shares jump premarket after FDA assigns breakthrough designation for AXS-05

    7:20 a.m. March 27, 2019

    - Ciara Linnane

  9. Harry Boxer: 3 biotech stocks with momentum

    11:39 a.m. March 22, 2019

    - Harry Boxer

  10. The stock market’s most important signal still hasn’t turned bullish

    12:25 p.m. Jan. 10, 2019

    - Lawrence G. McMillan

Analyst Ratings

/news/nonmarketwatch/company/us/axsm

Other News on AXSM

  1. Axsome Therapeutics (AXSM) Receives a Buy from William Blair

    2:25 p.m. Sept. 4, 2020

    - SmarterAnalyst

  2. Axsome Therapeutics (AXSM) Gets a Buy Rating from William Blair

    2:10 p.m. Aug. 21, 2020

    - SmarterAnalyst

  3. Axsome completes pre-NDA meeting for AXS-07

    8:21 a.m. Aug. 20, 2020

    - Seeking Alpha

  4. IPO Update: Harmony Biosciences Seeks $100 Million IPO

    5:45 p.m. Aug. 11, 2020

    - Seeking Alpha

  5. Axsome's (AXSM) Earnings Beat in Q2, Pipeline Progresses

    1:05 p.m. Aug. 11, 2020

    - Zacks.com

  6. 10-Q: AXSOME THERAPEUTICS, INC.

    5:08 p.m. Aug. 10, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  7. Axsome Therapeutics: Big Unfolding Catalyst

    5:19 a.m. Aug. 5, 2020

    - Seeking Alpha

  8. Harmony Biosciences Starts U.S. IPO Effort

    12:23 p.m. July 31, 2020

    - Seeking Alpha

  9. Loading more headlines...
/news/pressrelease/company/us/axsm

Press Releases on AXSM

  1. Axsome Therapeutics to Present at Upcoming Investor Conferences

    7:20 a.m. Sept. 3, 2020

    - GlobeNewswire

  2. Axsome Therapeutics to Present at Upcoming Investor Conferences

    7:00 a.m. Sept. 3, 2020

    - GlobeNewswire

  3. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.